193 related articles for article (PubMed ID: 23706367)
1. Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.
Chevreul K; Brunn M; Cadier B; Haour G; Eltchaninoff H; Prat A; Leguerrier A; Blanchard D; Fournial G; Iung B; Donzeau-Gouge P; Tribouilloy C; Debrux JL; Pavie A; Gilard M; Gueret P;
Arch Cardiovasc Dis; 2013 Apr; 106(4):209-19. PubMed ID: 23706367
[TBL] [Abstract][Full Text] [Related]
2. Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.
Dahle G; Rein KA; Fiane A; Fosse E; Khushi I; Hagen T; Mishra V
Scand Cardiovasc J; 2012 Dec; 46(6):345-52. PubMed ID: 22917262
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
[TBL] [Abstract][Full Text] [Related]
5. [The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].
Bartoli S; Saia F; Marrozzini C; Berti E; Guastaroba P; Fortuna D; Ciuca C; Moretti C; Marzocchi A; De Palma R
G Ital Cardiol (Rome); 2012 Jan; 13(1):50-8. PubMed ID: 22322472
[TBL] [Abstract][Full Text] [Related]
6. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
7. Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement.
Vergales JE; Wanchek T; Novicoff W; Kron IL; Lim DS
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1147-53. PubMed ID: 23857801
[TBL] [Abstract][Full Text] [Related]
8. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
Di Mario C; Eltchaninoff H; Moat N; Goicolea J; Ussia GP; Kala P; Wenaweser P; Zembala M; Nickenig G; Alegria Barrero E; Snow T; Iung B; Zamorano P; Schuler G; Corti R; Alfieri O; Prendergast B; Ludman P; Windecker S; Sabate M; Gilard M; Witowski A; Danenberg H; Schroeder E; Romeo F; Macaya C; Derumeaux G; Maggioni A; Tavazzi L;
EuroIntervention; 2013 Apr; 8(12):1362-71. PubMed ID: 23256965
[TBL] [Abstract][Full Text] [Related]
9. Registry of transcatheter aortic-valve implantation in high-risk patients.
Gilard M; Eltchaninoff H; Iung B; Donzeau-Gouge P; Chevreul K; Fajadet J; Leprince P; Leguerrier A; Lievre M; Prat A; Teiger E; Lefevre T; Himbert D; Tchetche D; Carrié D; Albat B; Cribier A; Rioufol G; Sudre A; Blanchard D; Collet F; Dos Santos P; Meneveau N; Tirouvanziam A; Caussin C; Guyon P; Boschat J; Le Breton H; Collart F; Houel R; Delpine S; Souteyrand G; Favereau X; Ohlmann P; Doisy V; Grollier G; Gommeaux A; Claudel JP; Bourlon F; Bertrand B; Van Belle E; Laskar M;
N Engl J Med; 2012 May; 366(18):1705-15. PubMed ID: 22551129
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
[TBL] [Abstract][Full Text] [Related]
11. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.
Arnold SV; Lei Y; Reynolds MR; Magnuson EA; Suri RM; Tuzcu EM; Petersen JL; Douglas PS; Svensson LG; Gada H; Thourani VH; Kodali SK; Mack MJ; Leon MB; Cohen DJ;
Circ Cardiovasc Interv; 2014 Dec; 7(6):829-36. PubMed ID: 25336467
[TBL] [Abstract][Full Text] [Related]
12. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.
Eltchaninoff H; Prat A; Gilard M; Leguerrier A; Blanchard D; Fournial G; Iung B; Donzeau-Gouge P; Tribouilloy C; Debrux JL; Pavie A; Gueret P;
Eur Heart J; 2011 Jan; 32(2):191-7. PubMed ID: 20843959
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
Doble B; Blackhouse G; Goeree R; Xie F
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
[TBL] [Abstract][Full Text] [Related]
15. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block.
Mouillet G; Lellouche N; Lim P; Meguro K; Yamamoto M; Deux JF; Monin JL; Bergoënd E; Dubois-Randé JL; Teiger E
Catheter Cardiovasc Interv; 2013 Apr; 81(5):882-7. PubMed ID: 22972678
[TBL] [Abstract][Full Text] [Related]
16. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
[TBL] [Abstract][Full Text] [Related]
17. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
[TBL] [Abstract][Full Text] [Related]
19. Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective.
Fraccaro C; Napodano M; Tarantini G
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1217-23. PubMed ID: 23456893
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter aortic valve implantation: the European experience.
Lange R; Bleiziffer S; Elhmidi Y; Piazza N
J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S17-21. PubMed ID: 23410775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
